ARCHIVE

• NEW PRODUCTS
  January 17, 2005

• Details on Japan-US Regulatory Reform Initiative Revealed: Korosho
  January 17, 2005

• Non-ICH Countries Interested in GCP, Pharmacovigilance: Yokohama Meeting
  January 17, 2005

• Korosho's Budget for Science, Technology to Hold Firm at \129 Bil.
  January 17, 2005

• Monkasho's Draft Budget Earmarks \81.8 Bil. for Life Science
  January 17, 2005

• METI's Draft Budget Earmarks \3.55 Bil. for Service Industry Creation
  January 17, 2005

• REGULATORY NEWS IN BRIEF
  January 17, 2005

• Meet the Leaders (39)
  January 17, 2005

• WEBSITE NEWS
  January 17, 2005

• MEETING
  January 17, 2005

• BULLTEIN
  January 17, 2005

• Blopress Passes Mevalotin as Top-selling Drug in 1st Half
  January 3, 2005

• AstraZeneca Aims at Gaining 20% of Statin Market by Crestor: Dr Kato
  January 3, 2005

• Tanabe Completes Enrollment of 1st 5,000 Remicade Users
  January 3, 2005

• Sales of Kyowa Hakko's Allelock Expected to Rise 35% in 2nd Half
  January 3, 2005

• Schering-Plough to Use New Formulation, New Evidence to Boost Sales of Claritin
  January 3, 2005

• Eisai Recieves A Positive Opinion for Zonegran Approval from EMEA
  January 3, 2005

• BUSINESS NEWS IN BRIEF
  January 3, 2005

• DIAGNOSTIC NEWS IN BRIEF
  January 3, 2005

• Reform Council, Korosho Finally Agree on "Mixed Medical Care"
  January 3, 2005

ページ

• « 先頭
• ‹ Prev
• …
• 488
• 489
• 490
• 491
• 492
• 493
• 494
• 495
• 496
• …
• Next ›
• 最終 »